Raffaele Porrini Selected Research

Dasatinib (BMS 354825)

1/2016

Frontline Dasatinib Treatment in a "Real-Life" Cohort of Patients Older than 65 Years with Chronic Myeloid Leukemia.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Raffaele Porrini Research Topics

Disease

4	Neoplasms (Cancer) 01/2022 - 01/2012
2	Primary Myelofibrosis (Myelosclerosis) 01/2022 - 03/2015
2	BCR-ABL Positive Chronic Myelogenous Leukemia (Chronic Myelogenous Leukemia) 01/2016 - 06/2011
1	Iron Overload 01/2022
1	Essential Thrombocythemia 09/2020
1	Splenomegaly 03/2016
1	Thrombosis (Thrombus) 03/2016
1	Philadelphia Chromosome 01/2012

Drug/Important Bio-Agent (IBA)

2	Deferasirox FDA Link 01/2022 - 06/2016
1	ruxolitinibIBA 01/2022
1	anagrelide (Agrylin)FDA LinkGeneric 09/2020
1	amsonic acid (DAS)IBA 01/2016
1	Dasatinib (BMS 354825)FDA Link 01/2016
1	Hemoglobins (Hemoglobin)IBA 03/2015
1	Hydroxyurea (Hydrea)FDA LinkGeneric 01/2012
1	Tyrosine Kinase InhibitorsIBA 06/2011

Therapy/Procedure

1	Therapeutics 03/2016